
Gain Insights into Competitive Landscapes Across China and Global Pipelines in Focused New Drug R&D Areas to Identify High-Potential Assets Through Multi-Dimensional Evaluation.
Identify Pipelines
Access the latest information on global new drug pipelines, from preclinical stages to marketed products. Pinpoint high-value pipelines through integrated dimensions such as R&D track ranking, clinical trial results, transaction details, and patent landscape.


Uncover Market Opportunities
Explore competitive landscapes within disease areas, drilling down into disease stages, patient populations, biomarkers, and therapy types. Identify unmet clinical needs and pinpoint potential high-value therapeutic areas by integrating clinical efficacy, epidemiology, and clinical guidelines.

Track New Drug R&D Progress in China and Globally to Enable Efficient Decision-Making.
Track Dynamics
Quickly gain insights into industry trends and competitive landscapes in China and globally through rich visualizations charts. Stay ahead with timely data updates and dynamic monitoring, capturing key intelligence as it emerges.


Precise Forecasting
Accurately forecast the market approval timeline for products of interest in China by analyzing historical approval data and leveraging proprietary predictive models.
Ten Core Data Modules
DXY Insight Database has built multiple specialized modules that comprehensively track new drug development by integrating intelligence across multiple dimensions including drugs, targets, indications, enterprises, ingredient classification, and technology types, building a world-leading platform for new drug intelligence.
Brand Strength

Calibrated Data
Rich, credible sources with timely updates

Easy-to-use Functionality
A wealth of first-of-its-kind & proprietary features, personalized filtering options

Professional Delivery
Comprehensive value-added services with rapid response
Who We Serve
DXY Insight Database delivers professional pharmaceutical data services to more than 3,000 companies worldwide, spanning the following client types.
Pharmaceutical
enterprise
Investment
agency
Consulting
company
R&D
agency
Medical device
enterprise
CRO
company



